Drug interactions
Encorafenib + Ropivacaine
Severity: Minor
Encorafenib and Ropivacaine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Encorafenib both inhibits and induces CYP3A4, so ropivacaine exposure could change in either direction. As CYP3A4 is a secondary pathway for ropivacaine, the clinical effect is expected to be small.
What this interaction means in plain words
Encorafenib and Ropivacaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Encorafenib belongs to Oncology; Ropivacaine belongs to Central Nervous System.
Why it happens
Mixed CYP3A4 inhibition and induction by encorafenib affecting the minor CYP3A4 route of ropivacaine metabolism.
What to do
No routine dose change is needed. Monitor anesthetic effect and signs of toxicity if used in prolonged infusion.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Encorafenib and Ropivacaine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ropivacaine
- Bupivacaine implant + Ropivacaine Major
- Bupivacaine liposome + Ropivacaine Major
- Amlodipine-benazepril + Ropivacaine Moderate
- Benazepril + Ropivacaine Moderate
- Captopril-hydrochlorothiazide + Ropivacaine Moderate
- Captopril + Ropivacaine Moderate
Other interactions of Encorafenib
Frequently asked questions
Can I take Encorafenib with Ropivacaine?
MediHelp rates the interaction as minor. Encorafenib and Ropivacaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Encorafenib both inhibits and induces CYP3A4, so ropivacaine exposure could change in either direction. As CYP3A4 is a secondary pathway for ropivacaine, the clinical effect is expected to be small.
How serious is the interaction between Encorafenib and Ropivacaine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed. Monitor anesthetic effect and signs of toxicity if used in prolonged infusion.
What other medicines interact with Ropivacaine?
MediHelp also lists interactions of Ropivacaine with, for example, Bupivacaine implant, Bupivacaine liposome, Amlodipine-benazepril. The full list is on the Ropivacaine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
